Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Dec 27, 2025

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 329.60	1.3%	30.0%	CHF 281.5b	CHF 324.39	PE29.7x	E13.1%	2.9%
NOVN Novartis	CHF 110.10	1.5%	24.0%	CHF 211.3b	CHF 106.64	PE18.6x	E5.0%	2.7%
GALD Galderma Group	CHF 164.10	0.8%	63.4%	CHF 39.0b	CHF 159.55	PE130.6x	E31.5%	0.08%
LONN Lonza Group	CHF 533.00	0.04%	-0.9%	CHF 37.4b	CHF 675.82	PE51.1x	E20.2%	0.8%
SDZ Sandoz Group	CHF 58.62	1.2%	57.8%	CHF 25.2b	CHF 53.17	PE141x	E29.6%	0.9%
DESN Dottikon ES Holding	CHF 341.00	2.7%	55.0%	CHF 4.7b	CHF 460.00	PE39x	n/a	0%
BANB Bachem Holding	CHF 59.45	4.4%	2.3%	CHF 4.5b	CHF 74.89	PE33.2x	E16.9%	1.4%
SFZN Siegfried Holding	CHF 74.20	0.1%	-24.6%	CHF 3.2b	CHF 108.67	PE21.1x	E10.9%	0.5%
COPN Cosmo Pharmaceuticals	CHF 105.20	4.6%	65.1%	CHF 1.7b	CHF 98.24	PE30.1x	E35.9%	1.8%
TECN Tecan Group	CHF 129.70	1.7%	-36.4%	CHF 1.6b	CHF 192.57	PE26.1x	E11.9%	2.3%
SKAN SKAN Group	CHF 52.20	5.8%	-33.2%	CHF 1.2b	CHF 70.33	PE72.6x	E32.8%	0.8%
IDIA Idorsia	CHF 4.43	10.1%	448.0%	CHF 1.1b	CHF 5.00	PS4.8x	E26.8%	n/a
KURN Kuros Biosciences	CHF 27.70	1.5%	25.1%	CHF 1.1b	CHF 32.80	PS10.5x	E60.9%	n/a
PPGN PolyPeptide Group	CHF 25.25	1.2%	-12.6%	CHF 833.0m	CHF 34.84	PS2.4x	E65.3%	0%
BSLN Basilea Pharmaceutica	CHF 55.20	3.2%	31.3%	CHF 678.3m	CHF 90.78	PE9.3x	E-24.7%	0%
NWRN Newron Pharmaceuticals	CHF 23.65	3.3%	168.1%	CHF 472.1m	CHF 30.59	PE20.1x	E38.4%	n/a
MMTX MindMaze Therapeutics Holding	CHF 2.26	6.6%	n/a	CHF 344.9m	CHF 3.56	n/a	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 12.88	4.4%	1.4%	CHF 172.2m	CHF 30.00	PS3.5x	S48.7%	n/a
BIOV BioVersys	CHF 25.00	4.6%	n/a	CHF 146.2m	CHF 55.00	PS111.7x	E-15.5%	n/a
XLS Xlife Sciences	CHF 24.20	1.3%	-2.4%	CHF 139.6m	n/a	PE4.5x	n/a	n/a
MOLN Molecular Partners	CHF 3.43	-4.3%	-22.9%	CHF 128.1m	CHF 9.00	PB1.3x	E-6.3%	n/a
CURN Curatis Holding	CHF 11.55	2.2%	-12.5%	CHF 58.2m	CHF 98.10	n/a	n/a	n/a
ADXN Addex Therapeutics	CHF 0.056	-0.4%	1.5%	CHF 6.5m	n/a	PS41x	S72.9%	n/a